Bio-Techne (TECH) Other financing activities (2009 - 2026)

Bio-Techne's Other financing activities history runs 18 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• On a quarterly basis, Other financing activities rose 101.45% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $64.4 million, a 5.88% decrease from a year earlier, with the FY2025 full-year figure at $51.7 million, down 15.09% from the prior year.
• Other financing activities climbed to $30.0 million in Q1 2026 per TECH's latest filing, from $4.7 million in the prior quarter.
• Across five years, Other financing activities topped out at $32.3 million in Q2 2023 and bottomed at -$67.6 million in Q2 2022.
• The 5-year median for Other financing activities is $14.4 million (2023), against an average of $8.0 million.
• Biggest YoY gain for Other financing activities was 685.84% in 2023; the steepest drop was 671.59% in 2023.
• Year by year, Other financing activities stood at $19.4 million in 2022, then sank by 72.85% to $5.3 million in 2023, then gained by 5.0% to $5.5 million in 2024, then slipped by 14.46% to $4.7 million in 2025, then surged by 532.18% to $30.0 million in 2026.
• Per Business Quant, the three latest TECH Other financing activities figures stand at $30.0 million (Q1 2026), $4.7 million (Q4 2025), and $23.5 million (Q3 2025).